MIRA INFORM REPORT

 

 

Report Date :

27.07.2013

 

IDENTIFICATION DETAILS

 

Name :

DVS BIOLIFE LIMITED

 

 

Registered Office :

Plot No.1162, Mayuri Nagar, Miyaour, Hyderabad – 500049, Andhra Pradesh

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

15.07.2004

 

 

Com. Reg. No.:

01-043664

 

 

Capital Investment / Paid-up Capital :

Rs.0.500 Million

 

 

CIN No.:

[Company Identification No.]

U24129AP2004PLC043664

 

 

Legal Form :

A Closely Held Public Limited Liability Company

 

 

Line of Business :

Manufacturer and Exporter of Beneficial Microorganisms, Herbal Extracts and Formulation etc. 

 

 

No. of Employees :

50 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (27)

 

RATING

STATUS

PROPOSED CREDIT LINE

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

 

Maximum Credit Limit :

USD 17000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Unknown

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having a moderate track record. The management has failed to file its financial for 2012 with the government department.

 

As per previous year record the company seems to have a small scale of operation.

 

However, trade relations are reported to be fair. Business is active. Payments are reported to be unknown.

 

The company can be considered for business dealings with great caution.

 

NOTES:

 

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31st, 2013

 

Country Name

Previous Rating

(31.12.2012)

Current Rating

(31.03.2013)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

 

INFORMATION PARTED BY

 

Name :

Mr. Vijaya Raghavan

Designation :

Key Executive

Contact No.:

91-9885446278

Date :

26.07.2013

 

 

LOCATIONS

 

Registered Office :

Plot No.1162, Mayuri Nagar, Miyaour, Hyderabad – 500049, Andhra Pradesh, India

Tel. No.:

Not Available

Mobile No.:

91-9966485444 (Mr. Vijaya)

Fax No.:

Not Available

E-Mail :

vijayaraghavan@agrilife.com

dr.venkatesh@agrilife.in

dvsbiolife@dvsbiolife.com

Website :

http://www.dvsbiolife.com

Location :

Owned

 

 

DIRECTORS

 

(AS ON 29.09.2011)

 

Name :

Mrs. Manjula Tangali Ramaiyengar

Designation :

Director

Address :

Flat 419A, Block A, Majestic Mansions, Begurpet, Hyderabad, Andhra Pradesh, India

Date of Birth/Age :

18.03.1959

Date of Appointment :

15.07.2004

DIN No.:

01900719

 

 

Name :

Mr. Gonuguntala Vijaya Paghavan

Designation :

Director

Address :

Plot No.23, Second Floor, Sancharouri Colony, New Bowenpally, Secunderabad, India 

Date of Birth/Age :

12.06.1948

Date of Appointment :

15.07.2004

DIN No.:

01520596

 

 

Name :

Mrs. Padma Ramachandra Murundi

Designation :

Director

Address :

Plot No.23, Second Floor, Sancharouri Colony, New Bowenpally, Secunderabad, India 

Date of Birth/Age :

21.06.1967

Date of Appointment :

15.07.2004

DIN No.:

01520583

 

 

Name :

Mr. Venkatesh Ramaswamy Iyengar Devanur

Designation :

Additional Director

Address :

Flat No.419 A, Block A, Magistic Mansion Shyamlal Building, Begumpet, Hyderabad – 500016, Andhra Pradesh, India

Date of Birth/Age :

30.05.1956

Date of Appointment :

05.03.2009

DIN No.:

01499923

 

 

KEY EXECUTIVES

 

Name :

Mr. Vijaya Raghavan

Designation :

Key Executive

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

(AS ON 29.09.2011)

 

Names of Shareholders

 

 

No. of Shares

 

 

 

Padma Ramachandra Murundi

 

12500

Manjula Tangali Ramaiyengar

 

12500

Gonuguntala Vijaya Paghavan

 

2500

Gargayee Venkatesh Iyengar

 

5000

Subbaraya G

 

5000

Venkata Lakshmi G

 

5000

Anuradha G

 

2500

Radhamma D

 

5000

 

 

 

Total

 

 

50000

 

 

(AS ON 30.09.2011)

Equity Shares Break – up

 

Category

 

 

Percentage

 

 

 

Directors or relatives of directors

 

100.00

 

 

 

Total

 

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Beneficial Microorganisms, Herbal Extracts and Formulation etc. 

 

 

Exports :

 

Products :

·         Beneficial Microorganisms

·         Herbal Extracts and Formulation

Countries :

·         Thailand

·         Vietnam

·         South Africa

 

 

Terms :

 

Selling :

Cash and Credit (30 days)

 

 

Purchasing :

Cash and Credit (30 days)

 

 

GENERAL INFORMATION

 

Customers :

Wholesalers and End Users

 

 

No. of Employees :

50 (Approximately)

 

 

Bankers :

·         Royal Bank of Scotland

Hyderabad Branch, Andhra Pradesh, India

 

·         ICICI Bank

Kukatpally Branch, Hyderabad, Andhra Pradesh, India

 

 

Facilities :

--

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Ankit and Company

Chartered Accountants

Address :

4-3-368, Bank Street, Hyderabad – 500095, Andhra Pradesh, India

PAN No.:

AAFFA7603Q

 

 

CAPITAL STRUCTURE

 

(AS ON 29.09.2011)

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

50000

Equity Shares

Rs.10/- each

Rs.0.500 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

50000

Equity Shares

Rs.10/- each

Rs.0.500 Million

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

0.500

0.500

0.500

2] Share Application Money

3.030

3.030

3.030

3] Reserves & Surplus

0.735

0.261

0.122

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

4.265

3.791

3.652

LOAN FUNDS

 

 

 

1] Secured Loans

0.000

0.000

0.000

2] Unsecured Loans

0.135

0.135

0.135

TOTAL BORROWING

0.135

0.135

0.135

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

4.400

3.926

3.787

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

0.000

0.000

0.000

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

0.426

0.625

0.476

 

Sundry Debtors

7.186

1.098

2.300

 

Cash & Bank Balances

3.603

3.249

1.542

 

Other Current Assets

1.888

0.746

0.000

 

Loans & Advances

0.000

0.000

0.048

Total Current Assets

13.103

5.718

4.366

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditor

8.439

1.723

0.805

 

Other Current Liabilities

0.000

0.000

0.000

 

Provisions

0.264

0.069

0.064

Total Current Liabilities

8.703

1.792

0.869

Net Current Assets

4.400

3.926

3.497

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.290

 

 

 

 

TOTAL

4.400

3.926

3.787

 

 

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2011

31.03.2010

31.03.2009

 

SALES

 

 

 

 

 

Income from Operations

13.762

4.388

5.007

 

 

Other Income

0.000

0.000

0.000

 

 

TOTAL                                     (A)

13.762

4.388

5.007

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Direct Expenses (Raw Materials and Manufacturing Expense)

10.462

2.878

3.369

 

 

Administrative and Selling Expenses

2.036

0.539

0.817

 

 

Research and development Expenses

0.090

0.086

0.086

 

 

Payment and Benefit to Employee

0.460

0.385

0.358

 

 

Deferred Revenue Expenses

0.000

0.290

0.290

 

 

Miscellaneous Expenses Written off

0.000

0.000

0.006

 

 

TOTAL                                     (B)

13.048

4.178

4.926

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

0.714

0.210

0.081

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

0.014

0.001

0.004

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

0.700

0.209

0.077

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

0.000

0.000

0.000

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

0.700

0.209

0.077

 

 

 

 

 

Less

TAX                                                                  (H)

0.225

0.070

0.026

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

0.475

0.139

0.051

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

0.261

0.122

0.071

 

 

 

 

 

 

BALANCE CARRIED TO THE B/S

0.736

0.261

0.122

 

 

 

 

 

 

Earnings Per Share (Rs.)

9.50

2.78

1.02

 

 

Particulars

 

 

31.03.2013

31.03.2012

Sales Turnover (Approximately)

 

40.000

30.000

 

Expected Sales (2013-14): Rs.50.000 Millions

 

The above information has been parted by Mr. Vijaya Raghavan.

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

PAT / Total Income

(%)

3.45

3.17

1.02

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

5.09

4.76

1.54

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

5.34

3.66

1.76

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.16

0.06

0.02

 

 

 

 

 

Debt Equity Ratio

(Total Debt/Networth)

 

0.03

0.04

0.04

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.51

3.19

5.02

 


 

LOCAL AGENCY FURTHER INFORMATION

 

 

Sr. No.

Check List by Info Agents

Available in Report

 (Yes / No)

1]

Year of Establishment

Yes

2]

Locality of the firm

Yes

3]

Constitutions of the firm

Yes

4]

Premises details

No

5]

Type of Business

Yes

6]

Line of Business

Yes

7]

Promoter's background

Yes

8]

No. of employees

Yes

9]

Name of person contacted

Yes

10]

Designation of contact person

Yes

11]

Turnover of firm for last three years

Yes

12]

Profitability for last three years

Yes

13]

Reasons for variation <> 20%

-----

14]

Estimation for coming financial year

Yes

15]

Capital in the business

Yes

16]

Details of sister concerns

No

17]

Major suppliers

No

18]

Major customers

No

19]

Payments terms

Yes

20]

Export / Import details (if applicable)

Yes

21]

Market information

-----

22]

Litigations that the firm / promoter involved in

-----

23]

Banking Details

Yes

24]

Banking facility details

No

25]

Conduct of the banking account

-----

26]

Buyer visit details

-----

27]

Financials, if provided

Yes 

28]

Incorporation details, if applicable

Yes 

29]

Last accounts filed at ROC

No 

30]

Major Shareholders, if available

Yes 

31]

Date of Birth of Proprietor/Partner/Director, if available

Yes

32]

PAN of Proprietor/Partner/Director, if available

No

33]

Voter ID No of Proprietor/Partner/Director, if available

No

34]

External Agency Rating, if available

No

 

 

OPERATIONS

 

The research products in the category of Probiolics have received good response from their Customers both in corporate, non-corporate and other sectors.

 

The Company is focused to develop Bio Solutions for Agriculture, Aquaculture, Poultry and Large Animals; and microbial solutions for Effluent Treatment / Environment Management. The Company has collaborated with an in-house R&D Centre of an associate company recognized by Dept of Scientific and Industrial Research, Govt of India. The Company has developed promising Bio Solutions and the same have been test marketed during the year and the response is very encouraging.

 

The Company has developed a unique probiotic complex for optimizing the feed conversion ratio in poultry and the same has been validated by research scholars at Veterinary College, Karnataka Veterinary, Animals and Fisheries Sciences University. The Company has developed and lest marketed a probiotic product for lactation optimization in milch animals.

 

The Company has developed Data Packages for BioPesticides like Karanjin, Vcrticillium Lecanii, Metarhizium Anisopliae and Beauveria Hassiana. The Dossiers have been submitted to the Central Insecticides Board, Govt of India for grant of Registrations. The Data Generation expenses have been shared with other companies to keep the costs al the minimum

 

 

FUTURE PROSPECTS

 

The Company expects to reach greater heights in future by and large barring unforeseen circumstances, the results are expected to be good in the year to come. The company has promising BioPestieides, BioFertilizers, Bio Agri Inputs, Animal Probiotics and Microbes for Effluent Treatment/ Environment Management. The Company proposes to raise funds for setting up state of the art Fermentation and downstream facility to manufacture products of Bio Solutions for Animals and Environment. The Company also envisages setting up of Microbiological/ Process Development laboratory in the near future.

 

 

INDEX OF CHARGES: NO CHARGES EXIST FOR COMPANY.

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.58.91

UK Pound

1

Rs.90.68

Euro

1

Rs.78.21

 

 

INFORMATION DETAILS

 

Information Gathered by :

JML

 

 

Report Prepared by :

NIT

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

27

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

 

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.